A Taskforce on Nature-related Financial Disclosures (TNFD, na sigla em inglês), iniciativa formada por líderes de grandes ...
A fabricante de máquinas Romi registrou lucro líquido de R$ 42,2 milhões no quarto trimestre de 2024, em queda de 17,7% sobre ...
No mercado internacional, serão divulgados os balanços da Bunge, Crédit Agricole, Disney, Equinor, GSK, Novo Nordisk, Santander, TotalEnergies, Toyota e Uber. Ford e Qualcom divulgarão após o ...
Petra começou na GlaxoSmithKline, passou para a Novartis International ... que há 13 anos é head de RH & GA (siglas de recursos humanos e administração geral) para a América Latina na Sumitomo ...
Now, GSK is ready to play catch-up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...
Feb 14 (Reuters) - Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK (GSK.L), opens new tab, the Financial Times reported on Friday. Citadel has ...
Feb 15 (Reuters) - The U.S. Food and Drug Administration approved British drugmaker GSK's (GSK.L), opens new tab combination vaccine to protect against meningococcal infection for use in people ...
GSK said it now e American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast.
GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. Last quarter, its operating ...
When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in. The content of this article is provided for information ...
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results